Search Results - "Stoddart, Angela"
-
1
Inhibition of WNT signaling in the bone marrow niche prevents the development of MDS in the Apcdel/+ MDS mouse model
Published in Blood (01-06-2017)“…There is accumulating evidence that functional alteration(s) of the bone marrow (BM) microenvironment contribute to the development of some myeloid disorders,…”
Get full text
Journal Article -
2
CUX1 regulates human hematopoietic stem cell chromatin accessibility via the BAF complex
Published in Cell reports (Cambridge) (28-05-2024)“…CUX1 is a homeodomain-containing transcription factor that is essential for the development and differentiation of multiple tissues. CUX1 is recurrently…”
Get full text
Journal Article -
3
Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia
Published in Chemico-biological interactions (19-03-2010)“…Therapy-related myelodysplastic syndrome and acute myeloid leukemia (t-MDS/t-AML) are late complications of cytotoxic therapy used in the treatment of…”
Get full text
Journal Article -
4
Plasticity of B cell receptor internalization upon conditional depletion of clathrin
Published in Molecular biology of the cell (01-05-2005)“…B cell antigen receptor (BCR) association with lipid rafts, the actin cytoskeleton, and clathrin-coated pits influences B cell signaling and antigen…”
Get full text
Journal Article -
5
The B Lymphocyte Adaptor Molecule of 32 Kilodaltons (Bam32) Regulates B Cell Antigen Receptor Internalization
Published in The Journal of immunology (1950) (01-11-2004)“…The B lymphocyte adaptor molecule of 32 kDa (Bam32) is an adaptor that plays an indispensable role in BCR signaling. In this study, we found that upon BCR…”
Get full text
Journal Article -
6
Knockdown of Hnrnpa0, a del(5q) gene, alters myeloid cell fate in murine cells through regulation of AU-rich transcripts
Published in Haematologica (Roma) (01-06-2014)“…The control of mRNA stability plays a central role in orchestrating gene-regulatory networks in hematopoietic cell growth, differentiation and tumorigenesis…”
Get full text
Journal Article -
7
-
8
Genetic pathways leading to therapy-related myeloid neoplasms
Published in Mediterranean journal of hematology and infectious diseases (01-01-2011)“…Therapy-related myeloid neoplasm (t-MN) is a distinctive clinical syndrome occurring after exposure to chemotherapy or radiotherapy. t-MN arises in most cases…”
Get full text
Journal Article -
9
Chromosome 7 Myeloid Tumor Suppressor Genes Cooperate in Chemotherapy Resistance
Published in Blood (15-11-2022)Get full text
Journal Article -
10
Lysosomal and Cytosolic Sialic Acid 9-O-Acetylesterase Activities Can Be Encoded by One Gene via Differential Usage of a Signal Peptide-encoding Exon at the N Terminus
Published in The Journal of biological chemistry (03-09-1999)“…9-O-Acetylation is one of the most common modifications of sialic acids, and it can affect several sialic acid-mediated recognition phenomena. We previously…”
Get full text
Journal Article -
11
Combined Deficiency of Chromosome 7 Myeloid Tumor Suppressors Enhances Chemotherapy Resistance
Published in Blood (02-11-2023)“…Monosomy 7 and del(7q) [-7/del(7q)] are recurrent in myeloid neoplasms and associated with chemoresistance. -7/del(7q) is identified in up to half of…”
Get full text
Journal Article -
12
3009 – COMBINED DEFICIENCY OF CHROMOSOME 7 MYELOID TUMOR SUPPRESSORS ENHANCES CHEMOTHERAPY RESISTANCE
Published in Experimental hematology (2023)Get full text
Journal Article -
13
Haploinsufficiency of del(5q) genes, Egr1 and Apc, cooperate with Tp53 loss to induce acute myeloid leukemia in mice
Published in Blood (13-02-2014)“…An interstitial deletion of chromosome 5, del(5q), is the most common structural abnormality in primary myelodysplastic syndromes (MDS) and therapy-related…”
Get full text
Journal Article -
14
EGR1 Haploinsufficiency Confers a Fitness Advantage to Hematopoietic Stem Cells Following Chemotherapy
Published in Experimental hematology (01-11-2022)“…•Loss of del(5q) gene, EGR1, imparts a clonal advantage to stem cells under stress.•Complete loss of EGR1 function is incompatible with malignant…”
Get full text
Journal Article -
15
Abstract 5598: Combined loss of the chromosome 7 genes CUX1 and EZH2 promotes chemotherapy resistance
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Abstract Monosomy 7 (-7) or del(7q) are recurrent in high-risk myeloid neoplasms, including up to 50% of myeloid neoplasms arising after prior exposure to…”
Get full text
Journal Article -
16
Cytotoxic Therapy–Induced Effects on Both Hematopoietic and Marrow Stromal Cells Promotes Therapy-Related Myeloid Neoplasms
Published in Blood cancer discovery (01-07-2020)Get full text
Journal Article -
17
Inhibition of Canonical WNT Signaling in the Bone Marrow Niche Prevents the Development of Disease in a Mouse MDS Model with Apc Haploinsufficiency
Published in Blood (02-12-2016)“…The myelodysplastic syndromes (MDS) include a spectrum of clonal hematopoietic stem cell (HSC) disorders that are characterized by ineffective hematopoiesis,…”
Get full text
Journal Article -
18
Haploinsufficient loss of multiple 5q genes may fine-tune Wnt signaling in del(5q) therapy-related myeloid neoplasms
Published in Blood (24-12-2015)Get full text
Journal Article -
19
Cytotoxic Exposure to Both Hematopoietic Stem and Progenitor Cells and the Bone Marrow Niche Cooperate to Promote Leukemogenesis in a Mouse Model of Therapy-Related Myeloid Neoplasms with a Del(5q)
Published in Blood (03-12-2015)“…A del(5q) is frequently noted in MDS, AML, and therapy-related myeloid neoplasms (t-MN) following alkylating agent therapy. Mutation/loss of the TP53 is gene…”
Get full text
Journal Article -
20
Egr1 and Apc Haploinsufficiency Cooperate in the Pathogenesis of Myeloid Neoplasia: A Mouse Model for Therapy-Related Myeloid Neoplasms with a Del(5q)
Published in Blood (16-11-2012)“…Abstract 117 Heterozygous deletions of the long arm of chromosome 5 are among the most common abnormalities in de novo (∼15% of patients) and therapy-related…”
Get full text
Journal Article